Johnson & Johnson vs Stryker Corporation
JNJ vs SYK — side-by-side comparison from reported financials. JNJ leads 6, SYK leads 4 of 10 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Stryker Corporation
SYK · Healthcare
$277.70+0.26%Mixed
| Metric | JNJ | SYK |
|---|---|---|
| Price | $261.79 | $277.70 |
| Market cap | $631B | $107B |
| Revenue (TTM) | $97.9B | $25.8B |
| Revenue growth | +5.6% | +10.8% |
| Net margin | 21.5% | 14.4% |
| Free cash flow | $22.2B | $4.70B |
| Net cash (debt) | ($27.8B) | ($11.8B) |
| 1-year price return | +37.0% | -25.0% |
| P/E | 29.9 | 28.5 |
| P/E vs own history (cheap-side %) | 16% | 99% |
| Dividend yield | 2.00% | 1.24% |
| Return on equity | 26% | 16% |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 140,800 | 56,000 |
Full résumé-style profiles: JNJ CV · SYK CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.